切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Aminopeptidases - AChE - Free Fatty Acid Receptors - Histone Deacetylases (HDACs)

48件产品中的 21-30

每页
清除全部
  1. (-)-Huperzine A
    A1932 (-)-Huperzine A
    中文名: 石杉碱甲
    Target: NMDA Receptors|AChE
    Summary: NMDA受体拮抗剂/AChE抑制剂
      ≥12.12 mg/mL
      insoluble in H2O
  2. Tosedostat (CHR2797)
    A4355 Tosedostat (CHR2797)
     1 Citation
    中文名: 托舍多特
    Target: Aminopeptidases
    Summary: 氨肽酶(Aminopeptidase)抑制剂
      ≥40.6 mg/mL
      insoluble in H2O
  3. M344
    A4105 M344
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC抑制剂
      ≥14.75 mg/mL
      insoluble in H2O
  4. AR-42 (OSU-HDAC42)
    A4104 AR-42 (OSU-HDAC42)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC抑制剂
      ≥15.62 mg/mL
      insoluble in H2O
  5. CI994 (Tacedinaline)
    A4102 CI994 (Tacedinaline)
     1 Citation
    中文名: 乙酰地那林,他地那兰
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC抑制剂
      ≥50 mg/mL
      insoluble in H2O
  6. Tubastatin A
    A4101 Tubastatin A
     6 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6抑制剂
      ≥10.75 mg/mL
      insoluble in H2O
  7. Valproic acid sodium salt (Sodium valproate)
    A4099 Valproic acid sodium salt (Sodium valproate)
    中文名: 丙戊酸钠
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC抑制剂
      ≥8.35 mg/mL
      ≥88.2 mg/mL
  8. PCI-24781 (CRA-024781)
    A4098 PCI-24781 (CRA-024781)
    Target: Histone Deacetylases (HDACs)
    Summary: Pan-HDAC抑制剂
      ≥11.75 mg/mL
      insoluble in H2O
  9. CUDC-907
    A4097 CUDC-907
    中文名: 非美诺司他
    Target: Histone Deacetylases (HDACs)|PI3K
    Summary: PI3K/HDAC抑制剂
      ≥25.45 mg/mL
      insoluble in H2O
  10. Belinostat (PXD101)
    A4096 Belinostat (PXD101)
     2 Citation
    中文名: 贝利司他
    Target: Histone Deacetylases (HDACs)
    Summary: 羟肟酸型HDAC抑制剂
      ≥15.92 mg/mL
      insoluble in H2O

48件产品中的 21-30

每页